|
1
|
Feng M, Gao W, Wang R, Chen W, Man YG,
Figg WD, Wang XW, Dimitrov DS and Ho M: Therapeutically targeting
glypican-3 via a conformation-specific single-domain antibody in
hepatocellular carcinoma. Proc Natl Acad Sci USA. 110:E1083–E1091.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Q, Liu J, Liu B, Xia J, Chen N, Chen
X, Cao Y, Zhang C, Lu C, Li M and Zhu R: Dihydromyricetin promotes
hepatocellular carcinoma regression via a p53 activation-dependent
mechanism. Sci Rep. 4:46282014.PubMed/NCBI
|
|
3
|
Zhang QY, Li R, Zeng GF, Liu B, Liu J, Shu
Y, Liu ZK, Qiu ZD, Wang DJ, Miao HL, et al: Dihydromyricetin
inhibits migration and invasion of hepatoma cells through
regulation of MMP-9 expression. World J Gastroenterol.
20:10082–10093. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsieh MJ, Lin CW, Yang SF, Chen MK and
Chiou HL: Glabridin inhibits migration and invasion by
transcriptional inhibition of matrix metalloproteinase 9 through
modulation of NF-κB and AP-1 activity in human liver cancer cells.
Br J Pharmacol. 171:3037–3050. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen TY, Li YC, Liu YF, Tsai CM, Hsieh YH,
Lin CW, Yang SF and Weng CJ: Role of MMP14 gene polymorphisms in
susceptibility and pathological development to hepatocellular
carcinoma. Ann Surg Oncol. 18:2348–2356. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alexander SP, Benson HE, Faccenda E,
Pawson AJ, Sharman JL, McGrath JC, Catterall WA, Spedding M, Peters
JA, Harmar AJ, et al: The Concise Guide to PHARMACOLOGY 2013/14:
Overview. Br J Pharmacol. 170:1449–1458. 2013. View Article : Google Scholar
|
|
7
|
Spanakis M, Kasmas S and Niopas I:
Simultaneous determination of the flavonoid aglycones diosmetin and
hesperetin in human plasma and urine by a validated GC/MS method:
In vivo metabolic reduction of diosmetin to hesperetin. Biomed
Chromatogr. 23:124–131. 2009. View
Article : Google Scholar
|
|
8
|
Chan BC, Ip M, Gong H, Lui SL, See RH,
Jolivalt C, Fung KP, Leung PC, Reiner NE and Lau CB: Synergistic
effects of diosmetin with erythromycin against ABC transporter
over-expressed methicillin-resistant Staphylococcus aureus1 (MRSA)
RN4220/pUL5054 and inhibition of MRSA pyruvate kinase.
Phytomedicine. 20:611–614. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meng JC, Zhu QX and Tan RX: New
antimicrobial mono-and sesquiterpenes from Soroseris hookeriana
subsp. erysimoides. Planta Med. 66:541–544. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chandler D, Woldu A, Rahmadi A, Shanmugam
K, Steiner N, Wright E, Benavente-García O, Schulz O, Castillo J
and Münch G: Effects of plant-derived polyphenols on TNF-alpha and
nitric oxide production induced by advanced glycation endproducts.
Mol Nutr Food Res. 54(Suppl 2): S141–S150. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liao W, Ning Z, Chen L, Wei Q, Yuan E,
Yang J and Ren J: Intracellular antioxidant detoxifying effects of
diosmetin on 2, 2-azobis (2-amidinopropane) dihydrochloride
(AAPH)-induced oxidative stress through inhibition of reactive
oxygen species generation. J Agric Food Chem. 62:8648–8654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Androutsopoulos VP, Mahale S, Arroo RR and
Potter G: Anticancer effects of the flavonoid diosmetin on cell
cycle progression and proliferation of MDA-MB 468 breast cancer
cells due to CYP1 activation. Oncol Rep. 21:1525–1528.
2009.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2–ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
14
|
Liu J, Shu Y, Zhang Q, Liu B, Xia J, Qiu
M, Miao H, Li M and Zhu R: Dihydromyricetin induces apoptosis and
inhibits proliferation in hepatocellular carcinoma cells. Oncol
Lett. 8:1645–1651. 2014.PubMed/NCBI
|
|
15
|
Chen H, Gao Y, Wu J, Chen Y, Chen B, Hu J
and Zhou J: Exploring therapeutic potentials of baicalin and its
aglycone baicalein for hematological malignancies. Cancer Lett.
354:5–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng G, Liu J, Chen H, Liu B, Zhang Q, Li
M and Zhu R: Dihydromyricetin induces cell cycle arrest and
apoptosis in melanoma SK-MEL-28 cells. Oncol Rep. 31:2713–2719.
2014.PubMed/NCBI
|
|
17
|
Liu B, Zhou Z, Zhou W, Liu J, Zhang Q, Xia
J, Liu J, Chen N, Li M and Zhu R: Resveratrol inhibits
proliferation in human colorectal carcinoma cells by inducing
G1/S-phase cell cycle arrest and apoptosis through
caspase/cyclin-CDK pathways. Mol Med Rep. 10:1697–1702.
2014.PubMed/NCBI
|
|
18
|
Androutsopoulos VP and Spandidos DA: The
flavonoids diosmetin and luteolin exert synergistic cytostatic
effects in human hepatoma HepG2 cells via CYP1A-catalyzed
metabolism, activation of JNK and ERK and P53/P21 up-regulation. J
Nutr Biochem. 24:496–504. 2013. View Article : Google Scholar
|
|
19
|
Kwon M, Lee SJ, Wang Y, Rybak Y, Luna A,
Reddy S, Adem A, Beaty BT, Condeelis JS and Libutti SK: Filamin A
interacting protein 1-like inhibits WNT signaling and MMP
expression to suppress cancer cell invasion and metastasis. Int J
Cancer. 135:48–60. 2014. View Article : Google Scholar :
|
|
20
|
Elkington PT and Friedland JS: Matrix
metalloproteinases in destructive pulmonary pathology. Thorax.
61:259–266. 2006. View Article : Google Scholar
|
|
21
|
Chen T, Li M, Zhang R and Wang H:
Dihydroartemisinin induces apoptosis and sensitizes human ovarian
cancer cells to carboplatin therapy. J Cell Mol Med. 13:1358–1370.
2009. View Article : Google Scholar
|
|
22
|
Hurst DR and Welch DR: Metastasis
suppressor genes at the interface between the environment and tumor
cell growth. Int Rev Cell Mol Biol. 286:107–180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin CW, Shen SC, Chien CC, Yang LY, Shia
LT and Chen YC: 12-O-tetradecanoylphorbol-13-acetate-induced
invasion/migration of glioblastoma cells through activating
PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression. J Cell Physiol.
225:472–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hidalgo M and Eckhardt SG: Development of
matrix metal-loproteinase inhibitors in cancer therapy. J Natl
Cancer Inst. 93:178–193. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hwang YP, Yun HJ, Kim HG, Han EH, Lee GW
and Jeong HG: Suppression of PMA-induced tumor cell invasion by
dihydroartemisinin via inhibition of PKCalpha/Raf/MAPKs and
NF-kappaB/AP-1-dependent mechanisms. Biochem Pharmacol.
79:1714–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He Q, Zhou X, Li S, Jin Y, Chen Z, Chen D,
Cai Y, Liu Z, Zhao T and Wang A: MicroRNA-181a suppresses salivary
adenoid cystic carcinoma metastasis by targeting MAPK-Snai2
pathway. Biochim Biophys Acta. 1830:5258–5266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Woo JH, Lim JH, Kim YH, Suh SI, Min DS,
Chang JS, Lee YH, Park JW and Kwon TK: Resveratrol inhibits phorbol
myristate acetate-induced matrix metalloproteinase-9 expression by
inhibiting JNK and PKC delta signal transduction. Oncogene.
23:1845–1853. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Reunanen N, Westermarck J, Häkkinen L,
Holmström TH, Elo I, Eriksson JE and Kähäri VM: Enhancement of
fibroblast collagenase (matrix metalloproteinase-1) gene expression
by ceramide is mediated by extracellular signal-regulated and
stress-activated protein kinase pathways. J Biol Chem.
273:5137–5145. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mauro LV, Grossoni VC, Urtreger AJ, Yang
C, Colombo LL, Morandi A, Pallotta MG, Kazanietz MG, Bal de Kier
Joffé ED and Puricelli LL: PKC Delta (PKCdelta) promotes tumoral
progression of human ductal pancreatic cancer. Pancreas.
39:e31–e41. 2010. View Article : Google Scholar
|
|
30
|
Hu CT, Cheng CC, Pan SM, Wu JR and Wu WS:
PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth
factor-induced migration of hepatoma cell HepG2. Cell Signal.
25:1457–1467. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu CT, Wu JR, Cheng CC, Wang S, Wang HT,
Lee MC, Wang LJ, Pan SM, Chang TY and Wu WS: Reactive oxygen
species-mediated PKC and integrin signaling promotes tumor
progression of human hepatoma HepG2. Clin Exp Metastasis.
28:851–863. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsieh HL, Wu CY and Yang CM: Bradykinin
induces matrix metalloproteinase-9 expression and cell migration
through a PKC-delta-dependent ERK/Elk-1 pathway in astrocytes.
Glia. 56:619–632. 2008. View Article : Google Scholar : PubMed/NCBI
|
